Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | LY01005 |
Synonyms | |
Therapy Description |
LY01005 is a extended release formulation of Goserelin, which is a synthetic analog of lutenizing hormone-releasing hormone (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
LY01005 | LY-01005|LY 01005 | Hormone - Anti-androgens 54 | LY01005 is a extended release formulation of Goserelin, which is a synthetic analog of lutenizing hormone-releasing hormone (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT03450109 | Phase I | LY01005 Goserelin | A Study to Assess LY01005 Versus Goserelin Comparator (ZOLADEX) in Patients With Prostate Cancer | Completed | USA | 0 |